Literature DB >> 28229087

Modeling Williams syndrome with induced pluripotent stem cells.

Thanathom Chailangkarn1, Alysson R Muotri2.   

Abstract

The development of induced pluripotent stem cells (iPSCs) like never before has opened novel opportunity to study diseases in relevant cell types. In our recent study, Williams syndrome (WS), a rare genetic neurodevelopmental disorder, that is caused by hemizygous deletion of 25-28 genes on chromosome 7, is of interest because of its unique cognitive and social profiles. Little is known about haploinsufficiency effect of those deleted genes on molecular and cellular phenotypes at the neural level due to the lack of relevant human cellular model. Using the cellular reprogramming approach, we reported that WS iPSC-derived neural progenitor cells (NPCs) has increased apoptosis and therefore increased doubling time, which could be rescued by complementation of frizzled 9, one of the genes typically deleted in WS. Moreover, WS iPSC-derived CTIP2-positive pyramidal neurons exhibit morphologic alterations including longer total dendrites and increasing dendritic spine number. In addition, WS iPSC-derived neurons show an increase in calcium transient frequency and synchronized activity likely due to increased number of dendritic spines and synapses. Our work integrated cross-level data from genetics to behavior of WS individuals and revealed altered cellular phenotypes in WS human NPCs and neurons that could be validated in other model systems such as magnetic resonance imaging (MRI) in live subjects and postmortem brain tissues.

Entities:  

Keywords:  Williams syndrome; disease modeling; iPSC

Year:  2017        PMID: 28229087      PMCID: PMC5305168          DOI: 10.1080/23262133.2017.1283187

Source DB:  PubMed          Journal:  Neurogenesis (Austin)        ISSN: 2326-2133


  58 in total

1.  GTF2IRD1 in craniofacial development of humans and mice.

Authors:  May Tassabehji; Peter Hammond; Annette Karmiloff-Smith; Pamela Thompson; Snorri S Thorgeirsson; Marian E Durkin; Nicholas C Popescu; Timothy Hutton; Kay Metcalfe; Agnes Rucka; Helen Stewart; Andrew P Read; Mark Maconochie; Dian Donnai
Journal:  Science       Date:  2005-11-03       Impact factor: 47.728

2.  Selective dendritic alterations in the cortex of Rett syndrome.

Authors:  D Armstrong; J K Dunn; B Antalffy; R Trivedi
Journal:  J Neuropathol Exp Neurol       Date:  1995-03       Impact factor: 3.685

3.  Frizzled 9 knock-out mice have abnormal B-cell development.

Authors:  Erik A Ranheim; Helen C K Kwan; Tannishtha Reya; Yu-Ker Wang; Irving L Weissman; Uta Francke
Journal:  Blood       Date:  2004-11-30       Impact factor: 22.113

4.  The elastin gene is disrupted by a translocation associated with supravalvular aortic stenosis.

Authors:  M E Curran; D L Atkinson; A K Ewart; C A Morris; M F Leppert; M T Keating
Journal:  Cell       Date:  1993-04-09       Impact factor: 41.582

5.  TFII-I, a candidate gene for Williams syndrome cognitive profile: parallels between regional expression in mouse brain and human phenotype.

Authors:  S K Danoff; H E Taylor; S Blackshaw; S Desiderio
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

6.  Nature and nurture: Williams syndrome across cultures.

Authors:  Carol Zitzer-Comfort; Teresa Doyle; Nobuo Masataka; Julie Korenberg; Ursula Bellugi
Journal:  Dev Sci       Date:  2007-11

7.  Brain-Region-Specific Organoids Using Mini-bioreactors for Modeling ZIKV Exposure.

Authors:  Xuyu Qian; Ha Nam Nguyen; Mingxi M Song; Christopher Hadiono; Sarah C Ogden; Christy Hammack; Bing Yao; Gregory R Hamersky; Fadi Jacob; Chun Zhong; Ki-Jun Yoon; William Jeang; Li Lin; Yujing Li; Jai Thakor; Daniel A Berg; Ce Zhang; Eunchai Kang; Michael Chickering; David Nauen; Cheng-Ying Ho; Zhexing Wen; Kimberly M Christian; Pei-Yong Shi; Brady J Maher; Hao Wu; Peng Jin; Hengli Tang; Hongjun Song; Guo-Li Ming
Journal:  Cell       Date:  2016-04-22       Impact factor: 41.582

8.  Smaller and larger deletions of the Williams Beuren syndrome region implicate genes involved in mild facial phenotype, epilepsy and autistic traits.

Authors:  Carmela Fusco; Lucia Micale; Bartolomeo Augello; Maria Teresa Pellico; Deny Menghini; Paolo Alfieri; Maria Cristina Digilio; Barbara Mandriani; Massimo Carella; Orazio Palumbo; Stefano Vicari; Giuseppe Merla
Journal:  Eur J Hum Genet       Date:  2013-06-12       Impact factor: 4.246

9.  Novel arterial pathology in mice and humans hemizygous for elastin.

Authors:  D Y Li; G Faury; D G Taylor; E C Davis; W A Boyle; R P Mecham; P Stenzel; B Boak; M T Keating
Journal:  J Clin Invest       Date:  1998-11-15       Impact factor: 14.808

10.  SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients.

Authors:  Aleksandr Shcheglovitov; Olesya Shcheglovitova; Masayuki Yazawa; Thomas Portmann; Rui Shu; Vittorio Sebastiano; Anna Krawisz; Wendy Froehlich; Jonathan A Bernstein; Joachim F Hallmayer; Ricardo E Dolmetsch
Journal:  Nature       Date:  2013-10-16       Impact factor: 49.962

View more
  7 in total

Review 1.  Modeling rare diseases with induced pluripotent stem cell technology.

Authors:  Ruthellen H Anderson; Kevin R Francis
Journal:  Mol Cell Probes       Date:  2018-01-05       Impact factor: 2.365

2.  Gtf2i and Gtf2ird1 mutation do not account for the full phenotypic effect of the Williams syndrome critical region in mouse models.

Authors:  Nathan Kopp; Katherine McCullough; Susan E Maloney; Joseph D Dougherty
Journal:  Hum Mol Genet       Date:  2019-10-15       Impact factor: 6.150

Review 3.  iPSC modeling of rare pediatric disorders.

Authors:  Bethany A Freel; Jordan N Sheets; Kevin R Francis
Journal:  J Neurosci Methods       Date:  2019-12-04       Impact factor: 2.390

Review 4.  Patient-derived iPSC modeling of rare neurodevelopmental disorders: Molecular pathophysiology and prospective therapies.

Authors:  K R Sabitha; Ashok K Shetty; Dinesh Upadhya
Journal:  Neurosci Biobehav Rev       Date:  2020-12-25       Impact factor: 8.989

Review 5.  Induced pluripotent stem cells as a tool to study brain circuits in autism-related disorders.

Authors:  Aline Vitrac; Isabelle Cloëz-Tayarani
Journal:  Stem Cell Res Ther       Date:  2018-08-23       Impact factor: 6.832

6.  Altered White Matter and microRNA Expression in a Murine Model Related to Williams Syndrome Suggests That miR-34b/c Affects Brain Development via Ptpru and Dcx Modulation.

Authors:  Meitar Grad; Ariel Nir; Gilad Levy; Sari Schokoroy Trangle; Guy Shapira; Noam Shomron; Yaniv Assaf; Boaz Barak
Journal:  Cells       Date:  2022-01-04       Impact factor: 6.600

7.  Williams syndrome: reduced orienting to other's eyes in a hypersocial phenotype.

Authors:  Johan Lundin Kleberg; Deborah Riby; Christine Fawcett; Hanna Björlin Avdic; Matilda A Frick; Karin C Brocki; Jens Högström; Eva Serlachius; Ann Nordgren; Charlotte Willfors
Journal:  J Autism Dev Disord       Date:  2022-04-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.